Notes:
Sales, means the sales volume of Prostate Cancer Drugs
Revenue, means the sales value of Prostate Cancer Drugs
This report studies sales (consumption) of Prostate Cancer Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Abbvie
Astra Zeneca
Janssen Pharmaceuticals
Sanofi
Amgen
Astellas Pharma
Bayer
BMS
Dendreon
Endo Pharmaceuticals
Ferring Pharmaceutical
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption) , revenue, market share and growth rate of Prostate Cancer Drugs in these countries, from 2011 to 2021 (forecast) , like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on sales, market share and growth rate of Prostate Cancer Drugs in each application, can be divided into
Application 1
Application 2
Application 3
Table of Contents
Europe Prostate Cancer Drugs Market Report 2016
1 Prostate Cancer Drugs Overview
1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Classification of Prostate Cancer Drugs
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Prostate Cancer Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Prostate Cancer Drugs Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Prostate Cancer Drugs (2011-2021)
1.5.1 Europe Prostate Cancer Drugs Sales and Growth Rate (2011-2021)
1.5.2 Europe Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
2 Europe Prostate Cancer Drugs by Manufacturers, Type and Application
2.1 Europe Prostate Cancer Drugs Market Competition by Manufacturers
2.1.1 Europe Prostate Cancer Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Prostate Cancer Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Prostate Cancer Drugs (Volume and Value) by Type
2.2.1 Europe Prostate Cancer Drugs Sales and Market Share by Type (2011-2016)
2.2.2 Europe Prostate Cancer Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Prostate Cancer Drugs (Volume and Value) by Countries
2.3.1 Europe Prostate Cancer Drugs Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Prostate Cancer Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Prostate Cancer Drugs (Volume) by Application
3 Germany Prostate Cancer Drugs (Volume, Value and Sales Price)
3.1 Germany Prostate Cancer Drugs Sales and Value (2011-2016)
3.1.1 Germany Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
3.1.2 Germany Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
3.1.3 Germany Prostate Cancer Drugs Sales Price Trend (2011-2016)
3.2 Germany Prostate Cancer Drugs Sales and Market Share by Manufacturers
3.3 Germany Prostate Cancer Drugs Sales and Market Share by Type
3.4 Germany Prostate Cancer Drugs Sales and Market Share by Application
4 France Prostate Cancer Drugs (Volume, Value and Sales Price)
4.1 France Prostate Cancer Drugs Sales and Value (2011-2016)
4.1.1 France Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
4.1.2 France Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
4.1.4 France Prostate Cancer Drugs Sales Price Trend (2011-2016)
4.2 France Prostate Cancer Drugs Sales and Market Share by Manufacturers
4.3 France Prostate Cancer Drugs Sales and Market Share by Type
4.4 France Prostate Cancer Drugs Sales and Market Share by Application
5 UK Prostate Cancer Drugs (Volume, Value and Sales Price)
5.1 UK Prostate Cancer Drugs Sales and Value (2011-2016)
5.1.1 UK Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
5.1.2 UK Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
5.1.5 UK Prostate Cancer Drugs Sales Price Trend (2011-2016)
5.2 UK Prostate Cancer Drugs Sales and Market Share by Manufacturers
5.3 UK Prostate Cancer Drugs Sales and Market Share by Type
5.4 UK Prostate Cancer Drugs Sales and Market Share by Application
6 Russia Prostate Cancer Drugs (Volume, Value and Sales Price)
6.1 Russia Prostate Cancer Drugs Sales and Value (2011-2016)
6.1.1 Russia Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
6.1.2 Russia Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
6.1.6 Russia Prostate Cancer Drugs Sales Price Trend (2011-2016)
6.2 Russia Prostate Cancer Drugs Sales and Market Share by Manufacturers
6.3 Russia Prostate Cancer Drugs Sales and Market Share by Type
6.4 Russia Prostate Cancer Drugs Sales and Market Share by Application
7 Italy Prostate Cancer Drugs (Volume, Value and Sales Price)
7.1 Italy Prostate Cancer Drugs Sales and Value (2011-2016)
7.1.1 Italy Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
7.1.2 Italy Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
7.1.7 Italy Prostate Cancer Drugs Sales Price Trend (2011-2016)
7.2 Italy Prostate Cancer Drugs Sales and Market Share by Manufacturers
7.3 Italy Prostate Cancer Drugs Sales and Market Share by Type
7.4 Italy Prostate Cancer Drugs Sales and Market Share by Application
8 Spain Prostate Cancer Drugs (Volume, Value and Sales Price)
8.1 Spain Prostate Cancer Drugs Sales and Value (2011-2016)
8.1.1 Spain Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
8.1.2 Spain Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
8.1.8 Spain Prostate Cancer Drugs Sales Price Trend (2011-2016)
8.2 Spain Prostate Cancer Drugs Sales and Market Share by Manufacturers
8.3 Spain Prostate Cancer Drugs Sales and Market Share by Type
8.4 Spain Prostate Cancer Drugs Sales and Market Share by Application
9 Benelux Prostate Cancer Drugs (Volume, Value and Sales Price)
9.1 Benelux Prostate Cancer Drugs Sales and Value (2011-2016)
9.1.1 Benelux Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
9.1.2 Benelux Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Prostate Cancer Drugs Sales Price Trend (2011-2016)
9.2 Benelux Prostate Cancer Drugs Sales and Market Share by Manufacturers
9.3 Benelux Prostate Cancer Drugs Sales and Market Share by Type
9.4 Benelux Prostate Cancer Drugs Sales and Market Share by Application
10 Europe Prostate Cancer Drugs Manufacturers Analysis
10.1 Abbvie
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Prostate Cancer Drugs Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Abbvie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Astra Zeneca
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Prostate Cancer Drugs Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Janssen Pharmaceuticals
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Prostate Cancer Drugs Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Sanofi
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Prostate Cancer Drugs Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Amgen
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Prostate Cancer Drugs Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Astellas Pharma
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Prostate Cancer Drugs Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Bayer
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Prostate Cancer Drugs Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Bayer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 BMS
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Prostate Cancer Drugs Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Dendreon
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Prostate Cancer Drugs Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Dendreon Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Endo Pharmaceuticals
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Prostate Cancer Drugs Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Ferring Pharmaceutical
11 Prostate Cancer Drugs Manufacturing Cost Analysis
11.1 Prostate Cancer Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Prostate Cancer Drugs
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Prostate Cancer Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Prostate Cancer Drugs Market Forecast (2016-2021)
14.1 Germany Prostate Cancer Drugs Sales Forecast (2016-2021)
14.2 France Prostate Cancer Drugs Sales Forecast (2016-2021)
14.3 UK Prostate Cancer Drugs Sales Forecast (2016-2021)
14.4 Russia Prostate Cancer Drugs Sales Forecast (2016-2021)
14.5 Italy Prostate Cancer Drugs Sales Forecast (2016-2021)
14.6 Spain Prostate Cancer Drugs Sales Forecast (2016-2021)
14.7 Benelux Prostate Cancer Drugs Sales Forecast (2016-2021)
14.8 Europe Prostate Cancer Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Prostate Cancer Drugs Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Prostate Cancer Drugs
Table Classification of Prostate Cancer Drugs
Figure Europe Sales Market Share of Prostate Cancer Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Prostate Cancer Drugs
Figure Europe Sales Market Share of Prostate Cancer Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure France Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure UK Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Prostate Cancer Drugs Sales and Growth Rate (2011-2021)
Figure Europe Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Table Europe Prostate Cancer Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Prostate Cancer Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostate Cancer Drugs Sales Share by Manufacturers
Figure 2016 Prostate Cancer Drugs Sales Share by Manufacturers
Table Europe Prostate Cancer Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Prostate Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Prostate Cancer Drugs Revenue Share by Manufacturers
Table 2016 Europe Prostate Cancer Drugs Revenue Share by Manufacturers
Table Europe Prostate Cancer Drugs Sales and Market Share by Type (2011-2016)
Table Europe Prostate Cancer Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Prostate Cancer Drugs by Type (2011-2016)
Figure Europe Prostate Cancer Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Prostate Cancer Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Prostate Cancer Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Prostate Cancer Drugs by Type (2011-2016)
Figure Europe Prostate Cancer Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Prostate Cancer Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Prostate Cancer Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Prostate Cancer Drugs by Countries (2011-2016)
Table Europe Prostate Cancer Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Prostate Cancer Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Prostate Cancer Drugs by Countries (2011-2016)
Table Europe Prostate Cancer Drugs Sales and Market Share by Application (2011-2016)
Table Europe Prostate Cancer Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Prostate Cancer Drugs by Application (2011-2016)
Figure Germany Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
Figure Germany Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Prostate Cancer Drugs Sales Price Trend (2011-2016)
Table Germany Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Prostate Cancer Drugs Sales by Type (2015 and 2016)
Table Germany Prostate Cancer Drugs Market Share by Type (2015 and 2016)
Table Germany Prostate Cancer Drugs Sales by Application (2015 and 2016)
Table Germany Prostate Cancer Drugs Market Share by Application (2015 and 2016)
Figure France Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
Figure France Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure France Prostate Cancer Drugs Sales Price Trend (2011-2016)
Table France Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)
Table France Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)
Table France Prostate Cancer Drugs Sales by Type (2015 and 2016)
Table France Prostate Cancer Drugs Market Share by Type (2015 and 2016)
Table France Prostate Cancer Drugs Sales by Application (2015 and 2016)
Table France Prostate Cancer Drugs Market Share by Application (2015 and 2016)
Figure UK Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
Figure UK Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure UK Prostate Cancer Drugs Sales Price Trend (2011-2016)
Table UK Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)
Table UK Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Prostate Cancer Drugs Sales by Type (2015 and 2016)
Table UK Prostate Cancer Drugs Market Share by Type (2015 and 2016)
Table UK Prostate Cancer Drugs Sales by Application (2015 and 2016)
Table UK Prostate Cancer Drugs Market Share by Application (2015 and 2016)
Figure Russia Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
Figure Russia Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Prostate Cancer Drugs Sales Price Trend (2011-2016)
Table Russia Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Prostate Cancer Drugs Sales by Type (2015 and 2016)
Table Russia Prostate Cancer Drugs Market Share by Type (2015 and 2016)
Table Russia Prostate Cancer Drugs Sales by Application (2015 and 2016)
Table Russia Prostate Cancer Drugs Market Share by Application (2015 and 2016)
Figure Italy Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
Figure Italy Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Prostate Cancer Drugs Sales Price Trend (2011-2016)
Table Italy Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Prostate Cancer Drugs Sales by Type (2015 and 2016)
Table Italy Prostate Cancer Drugs Market Share by Type (2015 and 2016)
Table Italy Prostate Cancer Drugs Sales by Application (2015 and 2016)
Table Italy Prostate Cancer Drugs Market Share by Application (2015 and 2016)
Figure Spain Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
Figure Spain Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Prostate Cancer Drugs Sales Price Trend (2011-2016)
Table Spain Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Prostate Cancer Drugs Sales by Type (2015 and 2016)
Table Spain Prostate Cancer Drugs Market Share by Type (2015 and 2016)
Table Spain Prostate Cancer Drugs Sales by Application (2015 and 2016)
Table Spain Prostate Cancer Drugs Market Share by Application (2015 and 2016)
Figure Benelux Prostate Cancer Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Prostate Cancer Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Prostate Cancer Drugs Sales Price Trend (2011-2016)
Table Benelux Prostate Cancer Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Prostate Cancer Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Prostate Cancer Drugs Sales by Type (2015 and 2016)
Table Benelux Prostate Cancer Drugs Market Share by Type (2015 and 2016)
Table Benelux Prostate Cancer Drugs Sales by Application (2015 and 2016)
Table Benelux Prostate Cancer Drugs Market Share by Application (2015 and 2016)
Table Prostate Cancer Drugs Basic Information List
Table Abbvie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Astra Zeneca Basic Information List
Table Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astra Zeneca Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Prostate Cancer Drugs Sales Market Share (2011-2016)
Table BMS Basic Information List
Table BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table BMS Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Dendreon Basic Information List
Table Dendreon Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Endo Pharmaceuticals Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Ferring Pharmaceutical Basic Information List
Table Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ferring Pharmaceutical Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure Germany Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Prostate Cancer Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Prostate Cancer Drugs Sales Forecast by Type (2016-2021)
Table Europe Prostate Cancer Drugs Sales Forecast by Application (2016-2021)
